Please login or register first to view this content.
Kidney Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Antidepressant, NSAID Identified as Culprits in SIADH Case
Factors Contributing to Darbepoetin Responsiveness in CKD
Two-Drug Combo Superior to Sunitinib as First-Line Therapy for Advanced RCC
Tenapanor Under Review for Hyperphosphatemia in CKD
FDA Rejects Terlipressin NDA for Hepatorenal Syndrome Type 1
Vadadustat Noninferior to Darbepoetin in CKD
Empagliflozin Beneficial in Heart Failure With Reduced Ejection Fraction
Guideline Updated for Nutrition in Chronic Kidney Disease
Boxed Warning Removed From Canagliflozin Labeling
FDA Cites Deficiencies in Veverimer NDA for Metabolic Acidosis in CKD
Ferric Citrate May Improve Iron Parameters Better Than Ferrous Sulfate in CKD
Orphan Drug Status Granted to Potential Polycystic Kidney Disease Treatment
Trial Investigating Dapagliflozin in CKD Meets All End Points
Caplacizumab Safe, Effective for Acquired Thrombotic Thrombocytopenic Purpura
Finerenone Found to Delay Progression of Diabetic Kidney Disease
FDA Committee Narrowly Votes in Favor of Terlipressin for Hepatorenal Syndrome Type 1
Tolvaptan Lowers Kidney Stone Risk in ADPKD
Limited ESA Use in COVID-19 Patients Recommended
